| United Therapeutics Corporation |
|
|
1110 Spring Street
Silver Spring, MD 20910 USA
phone:
(301) 608-9292
fax:
(301) 608-9291 |
| Symbol |
UTHR |
| Exchange |
NASDAQ |
| Founded |
0 |
| Employees |
|
|
|
www.unither.com |
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Biotechnology company focused on therapeutics to treat chronic and life-threatening diseases |
 |
| Management |
| Dan Balda, M.D., President and Chief Operating Officer, Medicomp, Inc.; John Ferrari, Chief Financial Officer and Treasurer; Peter C. Gonze, Chief Operating Officer, Unither Pharmaceuticals, Inc.; Roger Jeffs, Ph.D., President and Chief Operating Officer; Paul A. Mahon, J.D., Executive Vice President, Strategic Planning and General Counsel; Shola Oyewole, Chief Information Officer, MSc. Technology of Management Information Systems, BSc. Electronics & Computer Engineering, CNA, MCSE+Internet; Martine Rothblatt, Ph.D, J.D., M.B.A., Chairman and Chief Executive Officer; David Walsh, Ph.D., Executive Vice President and Chief Operating Officer, Production |
|
|
|
|
| Keywords |
| chronic disease, cardiovascular disease, infectious disease, oncological diseases, treprostinil sodium injection, pulmonary arterial hypertension, InfectiousDisease |
|
|
|
|
Description |
| United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of therapeutics to treat chronic and life-threatening diseases in three therapeutic areas: cardiovascular, infectious disease and oncology. |
 |
 |
|
|
|
|